vs

Side-by-side financial comparison of BANK OF NOVA SCOTIA (BNS) and Emerson Electric (EMR). Click either name above to swap in a different company.

BANK OF NOVA SCOTIA is the larger business by last-quarter revenue ($7.0B vs $4.6B, roughly 1.5× Emerson Electric). BANK OF NOVA SCOTIA runs the higher net margin — 23.8% vs 13.5%, a 10.3% gap on every dollar of revenue.

The Bank of Nova Scotia, operating as Scotiabank, is a Canadian multinational banking and financial services company headquartered in Toronto, Ontario. One of Canada's Big Five banks, it is the third-largest Canadian bank by assets and deposits. In 2023, the company's seat in Forbes Global 2000 was 88. Scotiabank serves over 25 million customers globally, offering personal and commercial banking, wealth management, corporate and investment services. With 88,000 employees and assets of approxi...

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

BNS vs EMR — Head-to-Head

Bigger by revenue
BNS
BNS
1.5× larger
BNS
$7.0B
$4.6B
EMR
Higher net margin
BNS
BNS
10.3% more per $
BNS
23.8%
13.5%
EMR

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
BNS
BNS
EMR
EMR
Revenue
$7.0B
$4.6B
Net Profit
$1.7B
$618.0M
Gross Margin
53.1%
Operating Margin
Net Margin
23.8%
13.5%
Revenue YoY
3.0%
Net Profit YoY
43.7%
EPS (diluted)
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNS
BNS
EMR
EMR
Q2 26
$4.6B
Q1 26
$7.0B
$4.3B
Q4 25
$7.2B
$4.3B
Q3 25
$6.9B
$4.9B
Q2 25
$6.6B
$4.6B
Q1 25
$4.4B
Q4 24
$4.2B
Q3 24
$4.6B
Net Profit
BNS
BNS
EMR
EMR
Q2 26
$618.0M
Q1 26
$1.7B
$606.0M
Q4 25
$1.6B
$605.0M
Q3 25
$1.8B
$637.0M
Q2 25
$1.5B
$586.0M
Q1 25
$485.0M
Q4 24
$585.0M
Q3 24
$996.0M
Gross Margin
BNS
BNS
EMR
EMR
Q2 26
53.1%
Q1 26
53.2%
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Operating Margin
BNS
BNS
EMR
EMR
Q2 26
Q1 26
Q4 25
17.8%
Q3 25
16.4%
Q2 25
16.1%
Q1 25
14.2%
Q4 24
18.6%
Q3 24
14.7%
Net Margin
BNS
BNS
EMR
EMR
Q2 26
13.5%
Q1 26
23.8%
13.9%
Q4 25
22.5%
13.9%
Q3 25
26.6%
13.1%
Q2 25
22.4%
12.9%
Q1 25
10.9%
Q4 24
14.0%
Q3 24
21.6%
EPS (diluted)
BNS
BNS
EMR
EMR
Q2 26
$1.10
Q1 26
$1.07
Q4 25
$1.07
Q3 25
$1.12
Q2 25
$1.04
Q1 25
$0.86
Q4 24
$1.02
Q3 24
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNS
BNS
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$6.4B
$1.8B
Total DebtLower is stronger
$13.4B
Stockholders' EquityBook value
$65.0B
$20.3B
Total Assets
$1077.5B
$42.1B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNS
BNS
EMR
EMR
Q2 26
$1.8B
Q1 26
$6.4B
$1.7B
Q4 25
Q3 25
$8.6B
Q2 25
$7.9B
Q1 25
Q4 24
Q3 24
Total Debt
BNS
BNS
EMR
EMR
Q2 26
$13.4B
Q1 26
$13.4B
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Stockholders' Equity
BNS
BNS
EMR
EMR
Q2 26
$20.3B
Q1 26
$65.0B
$20.3B
Q4 25
$20.3B
Q3 25
$62.4B
$20.3B
Q2 25
$63.1B
$19.9B
Q1 25
$19.2B
Q4 24
$20.5B
Q3 24
$21.6B
Total Assets
BNS
BNS
EMR
EMR
Q2 26
$42.1B
Q1 26
$1077.5B
$41.9B
Q4 25
$41.9B
Q3 25
$1032.7B
$42.0B
Q2 25
$1033.3B
$42.5B
Q1 25
$42.0B
Q4 24
$42.6B
Q3 24
$44.2B
Debt / Equity
BNS
BNS
EMR
EMR
Q2 26
0.66×
Q1 26
0.66×
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BNS
BNS
EMR
EMR
Operating Cash FlowLast quarter
$9.4B
Free Cash FlowOCF − Capex
$694.0M
FCF MarginFCF / Revenue
15.2%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
5.60×
TTM Free Cash FlowTrailing 4 quarters
$4.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BNS
BNS
EMR
EMR
Q2 26
Q1 26
$9.4B
Q4 25
$699.0M
Q3 25
$3.2B
$3.1B
Q2 25
$1.8B
$1.1B
Q1 25
$241.0M
Q4 24
$777.0M
Q3 24
$3.3B
Free Cash Flow
BNS
BNS
EMR
EMR
Q2 26
$694.0M
Q1 26
$602.0M
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
FCF Margin
BNS
BNS
EMR
EMR
Q2 26
15.2%
Q1 26
13.9%
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Capex Intensity
BNS
BNS
EMR
EMR
Q2 26
4.0%
Q1 26
2.2%
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Cash Conversion
BNS
BNS
EMR
EMR
Q2 26
Q1 26
5.60×
Q4 25
1.16×
Q3 25
1.73×
4.86×
Q2 25
1.22×
1.83×
Q1 25
0.50×
Q4 24
1.33×
Q3 24
3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons